Mural Oncology Sets Final Cash Consideration at $2.035 Per Share in XOMA Royalty Acquisition
XOMA Royalty, through its subsidiary, is set to acquire Mural Oncology plc for $2.035 per share. The acquisition, announced on August 20, 2025, is expected to close in December 2025, pending Irish High Court approval and other conditions. Details are available on Mural Oncology's website. This news was generated by Public Technologies using AI and is for informational purposes only.
XOMA Royalty, through its wholly-owned subsidiary, has agreed to acquire the entire issued and to be issued share capital of Mural Oncology plc. The acquisition, which follows a previous announcement made on August 20, 2025, is expected to close in early December 2025, pending satisfaction of outstanding closing conditions and approval by the Irish High Court. Further details about the transaction have been made available on Mural Oncology’s website. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mural Oncology plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9592803-en) on November 26, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
